Mark Barbour
Impact in
- Immunology top 10%
- IL-33, ST2, and ILC Pathways
- Immune Cell Function and Interaction
- Reproductive System and Pregnancy
Papers in
- Immunology 10
- IL-33, ST2, and ILC Pathways 6
- Immune Cell Function and Interaction 4
- interferon and immune responses 1
- Surgery 4
- Eosinophilic Esophagitis 4
- Co-authors
- Hui‐Rong Jiang (11 shared papers)Robin Plevin (2 shared papers)Debbie Allan (3 shared papers)Karen Fairlie‐Clarke (2 shared papers)Rong Mu (3 shared papers)C. W. M. Wilson (3 shared papers)Xiaoguang Tong (1 shared paper)Kezuo Hou (1 shared paper)
- Journals
- Immunology (2 papers)European Journal of Immunology (1 paper)Molecular Oncology (1 paper)Scientific Reports (1 paper)Frontiers in Immunology (1 paper)
- Partner nations
- United KingdomChinaAustralia
In The Last Decade
Mark Barbour
14 papers receiving 576 citations
Peers
Comparison fields: 5 of 122
- Immunology 285
- Biological Psychiatry 10
- Neurology 30
- Acoustics and Ultrasonics 3
- Surgery 140
Countries citing papers authored by Mark Barbour
This map shows the geographic impact of Mark Barbour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Barbour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Barbour more than expected).
Fields of papers citing papers by Mark Barbour
This network shows the impact of papers produced by Mark Barbour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Barbour. The network helps show where Mark Barbour may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Barbour, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 181 | |
| 2 | 2013 | 90 | |
| 3 | 2015 | 75 | |
| 4 | 2018 | 71 | |
| 5 | 2014 | 69 | |
| 6 | 2021 | 24 | |
| 7 | 1997 | 20 | |
| 8 | Role of IL-33/ST2 signaling pathway in systemic sclerosis and other fibrotic diseases. | 2019 | 16 |
| 9 | 2018 | 8 | |
| 10 | 2016 | 8 | |
| 11 | 2017 | 7 | |
| 12 | 2021 | 7 | |
| 13 | 2021 | 2 | |
| 14 | 2022 | 1 |
About Mark Barbour
Mark Barbour is a scholar working on Immunology, Surgery, Molecular Biology, Pathology and Forensic Medicine and Oncology, having authored 14 papers that have together received 579 indexed citations. Recurring topics across this work include IL-33, ST2, and ILC Pathways (6 papers), Eosinophilic Esophagitis (4 papers), Immune Cell Function and Interaction (4 papers), Cytokine Signaling Pathways and Interactions (2 papers), Neuroinflammation and Neurodegeneration Mechanisms (2 papers), interferon and immune responses (1 paper), Protein Tyrosine Phosphatases (1 paper) and Melanoma and MAPK Pathways (1 paper). The work is most often cited by research in Immunology (285 citations), Biological Psychiatry (10 citations), Neurology (30 citations), Acoustics and Ultrasonics (3 citations) and Surgery (140 citations). Mark Barbour has collaborated with scholars based in United Kingdom, China and Australia. Frequent co-authors include Hui‐Rong Jiang, Robin Plevin, Debbie Allan, Karen Fairlie‐Clarke, Rong Mu, C. W. M. Wilson, Xiaoguang Tong, Kezuo Hou, Yang Zhao and Chao Gao. Their work appears in journals such as Immunology, European Journal of Immunology, Molecular Oncology, Scientific Reports and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.